There is a reported trend of microdosing Ozempic, a type of GLP-1 drug, with some outlets exploring its potential benefits and risks. The practice appears to be associated with weight loss and possibly longevity, but its effectiveness and safety are uncertain. Some medical professionals are warning against microdosing GLP-1 drugs, suggesting it may not be a good idea, while others are examining its potential effects.